A New Era Begins: Visionaries Unite to Shape the Next 50 Years of Tourism at TOURISE

4.11.2025 16:35:00 CET | Business Wire | Press Release

Get ready to witness history in the making. Over three electrifying days, across two dynamic stages, more than 120 of the world’s most influential visionaries, change-makers, and industry pioneers will converge at the inaugural TOURISE Summit – the boldest global platform designed to unite governments, businesses, investors, and innovators under one roof to reshape the trillion-dollar tourism industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251104029567/en/

In a world grappling with fragmentation and uncertainty, TOURISE emerges as the ultimate catalyst for transformative collaboration and decisive action. This is not just a summit – it’s a movement. A year-round global platform where bold ideas become real-world solutions, and where the future of tourism is forged.

His Excellency Ahmed Al-Khateeb, Minister of Tourism of Saudi Arabia and Chairman of TOURISE, said, “TOURISE is where the world’s most diverse and powerful voices unite – public and private sector leaders and innovators from across every industry touched by tourism’s economic force. This summit is a launchpad for groundbreaking ideas and bold solutions that will drive our industry forward. With an extraordinary lineup of speakers, we’re set to spark conversations that will inspire action and shape a more inclusive, resilient, and future-ready tourism ecosystem.”

TOURISE 2025 is your front-row seat to the future; a place where public and private sectors, technology, finance, culture, and sustainability collide to rewrite the rules of global tourism for the next half-century.

Meet the speakers:

HE Yasir Al-Rumayyan, Governor, PIF Saudi Arabia
Ariane Gorin, CEO, Expedia
Ambassador Patricia Espinosa, Founder, onepoint5
Gloria Guevara, Interim CEO, World Travel & Tourism Council
Shaikha Nasser Al Nowais, Incoming Secretary General of UN Tourism
Luis Maroto, CEO, Amadeus
Francis Suarez, Mayor, Miami
Paul Griffiths, CEO, Dubai Airports
Lucia Penrod, Co-Founder & Owner, Nikki Beach
Sébastien Bazin, CEO, Accor
Eduardo Santander, CEO, European Travel Commission (ETC)
Harvey Goldsmith CBE, Founder, Nvisible Productions
Jean-Marie Tritant, CEO, Unibail-Rodamco-Westfield
Patrick Chalhoub, Executive Chairman, Chalhoub Group
Sir Ben Elliot, CEO & Co-Founder, Quintessentially & Hawthorn Advisors
Thomas Woldbye, CEO, Heathrow Airport
Paolo Barletta, CEO, Arsenale Group
Greg O'Hara, Founder and a Senior Managing Director, Certares
Martin Nydegger, CEO, Visit Switzerland
Steve Hafner, Co-Founder & CEO, Kayak.com
Abdullah Aldawood, Managing Director, Qiddiya Investment Company
David Woessner, Co-Founder & Partner, FutureOf
Fettah Tamince, Founder & Chairman, Rixos Hotels
Manfredi Lefebvre d’Ovidio, Chair of WTTC, Co-Chairman of Abercrombie & Kent, Chairman of the Heritage Group
Christie Travers-Smith, Director of EMEA Strategic Partnerships, Google Inc.

For the full list of distinguished speakers, visit TOURISE.com/speakers

Headline Sessions You Can’t Miss:

With an action-packed schedule, including exclusive experiences, the full program is now available on TOURISE.com and in the TOURISE app for guests.

FIRESIDE CHAT: The Next Chapter Of Tourism
Two of tourism’s global leaders, Gloria Guevara, Interim CEO WTTC, and Shaikha Nasser Al Nowais, Incoming Secretary General of UN Tourism, will discuss the sector’s influence and the need for collaboration and shared ambition to enable the sector for decades to come.

PANEL: Digitizing the Expected, Humanizing the Unexpected
Featuring Luis Maroto (Amadeus), Paul Griffiths (Dubai Airports) and Steve Hafner (Kayak.com). Explore how AI and automation create seamless travel — but it’s empathy and human connection that leave lasting impressions.

ICON TALK: Stories & Stakes Behind the Curtain
Harvey Goldsmith CBE (Nvisible Productions) shares five decades of shaping global entertainment and its powerful impact on tourism.

FIRESIDE CHAT: Betting on the Long Game
HE Yasir Al-Rumayyan (Governor of PIF) shares insights on placing the right bets, unlocking innovation at scale, and building the foundations of a more resilient, dynamic global economy.

Ready to be part of the rise?

The full program, exclusive experiences, and registration details are now live at www.TOURISE.com and in the TOURISE app for guests. Don’t miss your chance to join the world’s most powerful tourism minds and help shape the next 50 years of tourism.

Seats are limited. Register to attend at TOURISE.com

For media inquiries including interview opportunities with speakers and TOURISE leadership, please contact: MEDIA@TOURISE.com

About TOURISE

TOURISE is the world’s premier platform shaping a new horizon for global tourism.

Under the umbrella of the Saudi Ministry of Tourism, powered by the Saudi Tourism Authority, the inaugural TOURISE Summit will take place November 11–13, 2025, in Riyadh, Saudi Arabia. The event will convene visionaries from government, business, investment, tourism, and technology to drive transformative deals and deliver high-impact initiatives that redefine the future of the global tourism industry.

TOURISE ensures worldwide participation while offering access to decision-makers shaping the industry’s evolution. Following the Summit, TOURISE will continue as a year-round platform where bold ideas turn into real-world solutions.

This is where the next 50 years of tourism are shaped. Together, we are unstoppable.

For more information visit www.tourise.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251104029567/en/

Contacts

MEDIA@TOURISE.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom